These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 8895551)
1. Antagonism between estradiol and progestin on Bcl-2 expression in breast-cancer cells. Kandouz M; Siromachkova M; Jacob D; Chretien Marquet B; Therwath A; Gompel A Int J Cancer; 1996 Sep; 68(1):120-5. PubMed ID: 8895551 [TBL] [Abstract][Full Text] [Related]
2. Antiestrogens are pro-apoptotic in normal human breast epithelial cells. Somaï S; Chaouat M; Jacob D; Perrot JY; Rostène W; Forgez P; Gompel A Int J Cancer; 2003 Jul; 105(5):607-12. PubMed ID: 12740907 [TBL] [Abstract][Full Text] [Related]
3. Carboplatin treatment of antiestrogen-resistant breast cancer cells. Larsen MS; Yde CW; Christensen IJ; Lykkesfeldt AE Int J Oncol; 2012 Nov; 41(5):1863-70. PubMed ID: 22961366 [TBL] [Abstract][Full Text] [Related]
4. Effects of estrogen on apoptotic pathways in human breast cancer cell line MCF-7. Wang TT; Phang JM Cancer Res; 1995 Jun; 55(12):2487-9. PubMed ID: 7780952 [TBL] [Abstract][Full Text] [Related]
5. Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells. Teixeira C; Reed JC; Pratt MA Cancer Res; 1995 Sep; 55(17):3902-7. PubMed ID: 7641210 [TBL] [Abstract][Full Text] [Related]
6. Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer. Kim R; Tanabe K; Emi M; Uchida Y; Osaki A; Toge T Int J Oncol; 2005 Apr; 26(4):1025-31. PubMed ID: 15753998 [TBL] [Abstract][Full Text] [Related]
7. Effect of progestin treatment on estradiol-and growth factor-stimulated breast cancer cell lines. Cappelletti V; Miodini P; Fioravanti L; Di Fronzo G Anticancer Res; 1995; 15(6B):2551-5. PubMed ID: 8669822 [TBL] [Abstract][Full Text] [Related]
8. [Effect of tamoxifen on apoptosis and drug resistance of breast cancer cells in vitro]. Zheng J; Yao Z Zhonghua Zhong Liu Za Zhi; 2000 Jan; 22(1):55-7. PubMed ID: 11776601 [TBL] [Abstract][Full Text] [Related]
9. Tamoxifen-induced apoptosis in breast cancer cells relates to down-regulation of bcl-2, but not bax and bcl-X(L), without alteration of p53 protein levels. Zhang GJ; Kimijima I; Onda M; Kanno M; Sato H; Watanabe T; Tsuchiya A; Abe R; Takenoshita S Clin Cancer Res; 1999 Oct; 5(10):2971-7. PubMed ID: 10537367 [TBL] [Abstract][Full Text] [Related]
10. Paradoxical regulation of Bcl-2 family proteins by 17beta-oestradiol in human breast cancer cells MCF-7. Leung LK; Wang TT Br J Cancer; 1999 Oct; 81(3):387-92. PubMed ID: 10507761 [TBL] [Abstract][Full Text] [Related]
11. Estrogen increases intracellular p26Bcl-2 to p21Bax ratios and inhibits taxol-induced apoptosis of human breast cancer MCF-7 cells. Huang Y; Ray S; Reed JC; Ibrado AM; Tang C; Nawabi A; Bhalla K Breast Cancer Res Treat; 1997 Jan; 42(1):73-81. PubMed ID: 9116321 [TBL] [Abstract][Full Text] [Related]
12. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells. Liang Y; Wu J; Stancel GM; Hyder SM J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260 [TBL] [Abstract][Full Text] [Related]
13. Effect of decidualization on the expression of bax and bcl-2 in the rat uterine endometrium. Akcali KC; Khan SA; Moulton BC Endocrinology; 1996 Jul; 137(7):3123-31. PubMed ID: 8770938 [TBL] [Abstract][Full Text] [Related]
14. Hormonal modulation of HER-2/neu protooncogene messenger ribonucleic acid and p185 protein expression in human breast cancer cell lines. Read LD; Keith D; Slamon DJ; Katzenellenbogen BS Cancer Res; 1990 Jul; 50(13):3947-51. PubMed ID: 1972345 [TBL] [Abstract][Full Text] [Related]
15. The normal epithelial cell-specific 1 (NES1) gene is up-regulated by steroid hormones in the breast carcinoma cell line BT-474. Luo LY; Grass L; Diamandis EP Anticancer Res; 2000; 20(2A):981-6. PubMed ID: 10810385 [TBL] [Abstract][Full Text] [Related]
16. C-myc overexpression, c-mil, c-myb expression in a breast tumor cell line. Effects of estrogen and antiestrogen. Collyn-d'Hooghe M; Vandewalle B; Hornez L; Lantoine D; Revillion F; Lefebvre J; Kerckaert JP Anticancer Res; 1991; 11(6):2175-9. PubMed ID: 1776859 [TBL] [Abstract][Full Text] [Related]
17. Progestins reinitiate cell cycle progression in antiestrogen-arrested breast cancer cells through the B-isoform of progesterone receptor. McGowan EM; Russell AJ; Boonyaratanakornkit V; Saunders DN; Lehrbach GM; Sergio CM; Musgrove EA; Edwards DP; Sutherland RL Cancer Res; 2007 Sep; 67(18):8942-51. PubMed ID: 17875737 [TBL] [Abstract][Full Text] [Related]
18. Induction of apoptosis in mammary gland by a pure anti-estrogen ICI 182780. Lim KB; Ng CY; Ong CK; Ong CS; Tran E; Nguyen TT; Chan GM; Huynh H Breast Cancer Res Treat; 2001 Jul; 68(2):127-38. PubMed ID: 11688516 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of HER2 modulates bcl-2, bcl-XL, and tamoxifen-induced apoptosis in human MCF-7 breast cancer cells. Kumar R; Mandal M; Lipton A; Harvey H; Thompson CB Clin Cancer Res; 1996 Jul; 2(7):1215-9. PubMed ID: 9816290 [TBL] [Abstract][Full Text] [Related]
20. Progestin effects on long-term growth, death, and Bcl-xL in breast cancer cells. Moore MR; Conover JL; Franks KM Biochem Biophys Res Commun; 2000 Nov; 277(3):650-4. PubMed ID: 11062008 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]